MiLife change name to Imperative Health and completes additional funding of USD4m

A spin-out from Unilever Corporate Research (UCR), MiLife, changed its name to Imperative Health and completed an additional funding of USD4m for development and growth, the company stated on Tuesday.

The name change reflects its strategic direction and focuses to manage health risks of diabetes, high blood pressure, obesity and raised cholesterol leveraging five years of research from within Unilever, the company added.

New Venture Partners became joint investors in 2009. Imperative appointed Chris Jessop as chairman and CEO of the company, who recruited healthcare industry experts Dr Sabine Donnai as director and CMO and Clive Pinder as a non-executive director.

Â

Jessop most recently was the CE of Nuffield Health Wellbeing, comprising Nuffield Proactive Health and earlier with Cannons Health & Fitness besides being managing director of BUPA Wellness, a UK healthcare company.

Dr Donnai a private physician and experienced medical director of major healthcare companies was earlier medical director of Nuffield Health Wellbeing, managing director of Prestige Health and a regional clinical director of BUPA. She will head the clinical development of the Imperative solution globally and its clinical governance as well.

As the CEO of Vielife, an on-line healthcare management company, Pinder delivered health and wellbeing programmes through clients like the Department of Health, Blue Cross Blue Shield, Citibank, BUPA, Standard Life, CIGNA, GSK, Unilever, National Grid and Royal Bank of Scotland. He will focus on Imperative's expansion into the US market.

((Comments on this story may be sent to [email protected]))